DealShare, once valued at $1.7 billion, may sell to Truemeds for little over $90 million - The Economic Times

DealShare, once valued at $1.7 billion, is in advanced talks to be acquired by online pharmacy Truemeds in a share-swap deal. The transaction would value DealShare at a little over its cash balance, while Truemeds would issue shares to its investors. The deal would mark a steep valuation reset for DealShare.

Raccontata daeconomictimes.indiatimes.com